You have 9 free searches left this month | to do more

rhil-15

Rhil 15 is a drug used to treat Anaplastic Large Cell Lymphoma, B-Cell, Chronic, and other conditions. Rhil 15 is being actively studied in 2 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)National Institutes of Health Clinical CenterKevin Conlon, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia - 2021
Terminated
Has Results
  • Leukemia
  • +3 more
  • rhIL-15
  • Obinutuzumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-03-11
Mar 11, 2022
N
Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma - 2021
Completed
  • Clear-Cell Renal Carcinoma
  • rhIL-15
  • Avelumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-09-21
Sep 21, 2021
N
Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers
Recruiting
  • Metastatic Solid Tumors
  • Treatment-Refractory Cancers
  • rhIL-15
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies
Active, not recruiting
  • Peripheral T-cell Lymphoma NOS
  • +3 more
  • rhIL-15
  • Avelumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-02-02
Feb 2, 2022